REQUEST A DEMO
Total
USD $0.00
Search more companies

Bene Pharma S.R.O. V Konkurze (Slovakia)

Main Activities: Real Estate
Full name: Bene Pharma S.R.O. V Konkurze Profile Updated: October 10, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Bene Pharma S.R.O. V Konkurze is a company based in Slovakia, with its head office in Presov. The enterprise operates in the Real Estate industry. It was incorporated on September 11, 2007. It currently has a total number of 2 - 3 (2023) employees. The company’s latest financial report indicates a net sales revenue drop of 9.68% in 2022. Its’ total assets recorded a growth of 1.65%. In 2022, Bene Pharma S.R.O. V Konkurze’s net profit margin decreased by 18.77%.

Headquarters
Jazdecka, 1/A
Presov; Presovsky; Postal Code: 08001

Contact Details: Purchase the Bene Pharma S.R.O. V Konkurze report to view the information.

Basic Information
Total Employees:
Purchase the Bene Pharma S.R.O. V Konkurze report to view the information.
Outstanding Shares:
Purchase the Bene Pharma S.R.O. V Konkurze report to view the information.
Registered Capital:
Purchase the Bene Pharma S.R.O. V Konkurze report to view the information.
Incorporation Date:
September 11, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Liquidator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Bene Pharma S.R.O. V Konkurze report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-9.68%
Total operating revenue
-9.68%
Operating profit (EBIT)
-55.27%
EBITDA
-26.85%
Net Profit (Loss) for the Period
-79.17%
Total assets
1.65%
Total equity
-68.89%
Operating Profit Margin (ROS)
-15.78%
Net Profit Margin
-18.77%
Return on Equity (ROE)
-5.1%
Quick Ratio
-0.01%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?